Changing the Conversation: A Critical Bioethics Response to the Opioid Crisis

[1]  D. Steel,et al.  Our Life Depends on This Drug: Competence, Inequity, and Voluntary Consent in Clinical Trials on Supervised Injectable Opioid Assisted Treatment , 2017, The American journal of bioethics : AJOB.

[2]  M. Karamouzian,et al.  The lessons learned from the fentanyl overdose crises in British Columbia, Canada. , 2017, Addiction.

[3]  J. Leider,et al.  Ethical Guidance for Disaster Response, Specifically Around Crisis Standards of Care: A Systematic Review , 2017, American journal of public health.

[4]  Daniel Ciccarone,et al.  Fentanyl in the US heroin supply: A rapidly changing risk environment. , 2017, The International journal on drug policy.

[5]  E. Nadelmann,et al.  Two steps forward, one step back: current harm reduction policy and politics in the United States , 2017, Harm Reduction Journal.

[6]  H. Pollack,et al.  Addressing the Fentanyl Threat to Public Health. , 2017, The New England journal of medicine.

[7]  V. Árnason.  Toward critical bioethics. , 2015, Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees.

[8]  Geoffrey Poitras.  OxyContin, prescription opioid abuse and economic medicalization , 2012 .

[9]  V. Berridge.  Heroin prescription and history. , 2009, The New England journal of medicine.

[10]  A. Hedgecoe,et al.  Critical bioethics: beyond the social science critique of applied ethics. , 2004, Bioethics.

[11]  A. Uchtenhagen.  Heroin-assisted treatment in Switzerland: a case study in policy change. , 2010, Addiction.